"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
(Generic versions may still be available.)
Ilotycin Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Ilotycin (erythromycin) Ointment is an antibiotic used to treat superficial ocular (eye) infections, and to prevent neonatal gonococcal or chlamydial conjunctivitis. The brand name Ilotycin is discontinued, but generic versions may be available. Common side effects of Ilotycin (erythromycin) Ointment include minor eye irritations, stinging, burning, redness, temporary blurred vision, and hypersensitivity reactions.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Ilotycin FDA Prescribing Information: Side Effects
The most frequently reported adverse reactions are minor ocular irritations, redness, and hypersensitivity reactions.
To report SUSPECTED ADVERSE REACTIONS, contact Fera Pharmaceuticals, LLC at (414) 434-6604 Monday-Friday 9am-5pm EST or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Read the entire FDA prescribing information for Ilotycin (Erythromycin)
Additional Ilotycin Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.